HLB Inc
KOSDAQ:028300
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HLB Inc
KOSDAQ:028300
|
KR |
|
E
|
Euroapi SAS
F:940
|
FR |
Intrinsic Value
The intrinsic value of HLB Inc (028300) under the Base Case is 2 752.53 KRW per share. Compared with the current market price of 41 600 KRW, the stock appears Overvalued by 93% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What HLB Does
HLB Inc. is a South Korean biotech and healthcare company best known for developing cancer drugs and related medical products. Its core work is drug research, clinical development, and commercializing medicines through its own businesses and subsidiaries. It also has interests in medical devices and diagnostics, which gives it a broader role in the healthcare value chain than a pure drug developer.
- Headquarters
- Korea KR
- Employees
- 153
- IPO date
- Jul 27, 1996
Revenue & Expenses Breakdown
HLB Inc
Earnings Waterfall
HLB Inc
The intrinsic value for HLB Inc (028300) under the Base Case is 2 752.53 KRW.
Compared with the current market price of 41 600 KRW, the stock appears Overvalued by 93% .